On Tuesday, Revolution Medicines Inc (NASDAQ: RVMD) opened higher 1.35% from the last session, before settling in for the closing price of $39.93. Price fluctuations for RVMD have ranged from $29.17 to $62.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -38.52% over the past five years. Company’s average yearly earnings per share was noted -32.12% at the time writing. With a float of $161.93 million, this company’s outstanding shares have now reached $186.26 million.
Let’s look at the performance matrix of the company that is accounted for 534 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Revolution Medicines Inc (RVMD) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Revolution Medicines Inc is 13.07%, while institutional ownership is 93.64%. The most recent insider transaction that took place on Mar 20 ’25, was worth 79,008. In this transaction General Counsel of this company sold 2,041 shares at a rate of $38.71, taking the stock ownership to the 57,723 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Officer proposed sale 2,041 for $38.75, making the entire transaction worth $79,089.
Revolution Medicines Inc (RVMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -32.12% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.42% during the next five years compared to -27.80% drop over the previous five years of trading.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Check out the current performance indicators for Revolution Medicines Inc (RVMD). In the past quarter, the stock posted a quick ratio of 13.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.00, a number that is poised to hit -1.15 in the next quarter and is forecasted to reach -5.08 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Revolution Medicines Inc (NASDAQ: RVMD) saw its 5-day average volume 1.27 million, a negative change from its year-to-date volume of 1.61 million. As of the previous 9 days, the stock’s Stochastic %D was 41.56%. Additionally, its Average True Range was 1.90.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 68.61%, which indicates a significant increase from 56.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.45% in the past 14 days, which was higher than the 49.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $37.81, while its 200-day Moving Average is $43.78. Nevertheless, the first resistance level for the watch stands at $41.02 in the near term. At $41.56, the stock is likely to face the second major resistance level. The third major resistance level sits at $42.30. If the price goes on to break the first support level at $39.74, it is likely to go to the next support level at $39.00. The third support level lies at $38.46 if the price breaches the second support level.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
There are currently 186,268K shares outstanding in the company with a market cap of 7.54 billion. Presently, the company’s annual sales total 0 K according to its annual income of -600,090 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -213,420 K.
